Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3700 Southern Blvd
Ste 401
Dayton, OH 45429Phone+1 937-395-8020Fax+1 937-281-3908
Education & Training
University of MichiganFellowship, Gynecologic Oncology, 2001 - 2003
Wright State UniversityResidency, Obstetrics and Gynecology, 1997 - 2001- Wright State UniversityInternship, Surgery, 1996 - 1997
- Wright State University Boonshoft School of MedicineClass of 1996
The Ohio State UniversityB.S., Biology , 1988 - 1992- Ohio stateB.S., Biology , 1988 - 1988
Certifications & Licensure
OH State Medical License 1997 - 2026- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsRRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancerDaniel Morgensztern, Michal G. Rose, Saiama N. Waqar, John C. Morris, Patrick C. Ma
British Journal of Cancer. 2019-07-30 - 24 citationsImpact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.Elizabeth M Swisher, Carol Aghajanian, David M O'Malley, Gini F Fleming, Scott H Kaufmann
Gynecologic Oncology. 2022-02-01 - 46 citationsProspective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG StudyKrishnansu S. Tewari, Michael W. Sill, Bradley J. Monk, Richard T. Penson, Harry J. Long
Clinical Cancer Research. 2015-12-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
